ATRA · Atara Biotherapeutics, Inc. · Held by Funds
$9.25
-0.15 (-1.60%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our existing cash, cash equivalents and short-term investments as of June 30, 2026 will not be sufficient to fund our planned operations for at least the next twelve months from the date of issuance of these financial statements. These conditions raise substantial doubt about our ability to continue as a going concern for at least 12 months after the issuance of the accompanying condensed consolidated financial statements.”View the 10-Q filed Aug 12, 2026
Market Cap
$82.31M
Shares
10.04M
Volume · Oct 5
39.32K
Avg daily vol (3M)
57.61K
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ATRA
21 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 158,646 | $1,821,256 | 0.00% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 82,758 | $950,062 | 0.00% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 29,408 | $309,078 | 0.00% | Long | 2026-05-31 | |
| iShares Micro-Cap ETF | IWC | 17,227 | $197,766 | 0.01% | Long | 2026-06-30 | |
| VIP Disciplined Small Cap Portfolio | — | 16,238 | $186,412 | 0.03% | Long | 2026-06-30 | |
| Ultra-Small Company Market Fund | BRSIX | 14,000 | $160,720 | 0.11% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 10,479 | $110,134 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 8,665 | $91,069 | 0.00% | Long | 2026-05-31 | |
| Goldman Sachs Human Evolution ETF | — | 4,721 | $63,639 | 0.13% | Long | 2020-08-31 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 4,612 | $48,472 | 0.00% | Long | 2026-05-31 | |
| Defiance Nasdaq Junior Biotechnology ETF | — | 1,940 | $34,726 | 0.48% | Long | 2021-09-30 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 2,844 | $32,649 | 0.00% | Long | 2026-06-30 | |
| VANGUARD BALANCED INDEX FUND | — | 2,799 | $32,133 | 0.00% | Long | 2026-06-30 | |
| ProShares UltraPro Nasdaq Biotechnology | — | 1,256 | $15,260 | 0.08% | Long | 2020-02-29 | |
| Schwab Total Stock Market Index Fund | SWTSX | 1,643 | $13,768 | 0.00% | Long | 2026-07-31 | |
| 1290 VT Micro Cap Portfolio | — | 1,147 | $13,168 | 0.01% | Long | 2026-06-30 | |
| iShares Evolved U.S. Innovative Healthcare ETF | — | 2,136 | $6,472 | 0.02% | Long | 2022-07-31 | |
| Principal Healthcare Innovators ETF | — | 446 | $3,791 | 0.02% | Long | 2024-06-30 | |
| Total Stock Market Index Trust | — | 210 | $2,411 | 0.00% | Long | 2026-06-30 | |
| Dimensional U.S. Small Cap ETF | DFAS | 135 | $1,131 | 0.00% | Long | 2026-07-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 1,464 | $16,807 | 0.00% | Short | 2026-06-30 |
Showing 1–21 of 21 positions